Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-25 @ 8:09 PM
Study NCT ID:
NCT01132235
Status:
UNKNOWN
Last Update Posted:
2010-05-28
First Post:
2010-05-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use
Sponsor:
Florida Academic Dermatology Centers
Organization:
Study Overview
Official Title:
An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use
Status:
UNKNOWN
Status Verified Date:
2010-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ENBRECAP2009
Brief Summary:
The purpose of this study is to evaluate the efficacy of re-treatment with etanercept 50mg subcutaneous injections twice weekly for 12 weeks in subjects who have previously been treated etanercept and efficacy diminished.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: